LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Evaluation of a novel point‐of‐care test kit, ABSOGEN™ PCT, in semi‐quantitative measurement of procalcitonin in whole blood

Photo by nci from unsplash

In response to inflammation, procalcitonin plasma concentrations increase more rapidly than other acute‐phase reactants and higher values are associated with severe disease. Procalcitonin measurements assist in determining whether antibiotic therapy… Click to show full abstract

In response to inflammation, procalcitonin plasma concentrations increase more rapidly than other acute‐phase reactants and higher values are associated with severe disease. Procalcitonin measurements assist in determining whether antibiotic therapy should be used. point‐of‐care testing (POCT) is performed for early decision making about additional testing or therapy. The ABSOGEN™ PCT (Bumyoungbio, Inc., Suwon, Korea) is a rapid novel semi‐quantitative immunochromatographic PCT assay that analyses whole blood samples. We compared the patient quantitative test results to ABSOGEN™ PCT test results.

Keywords: point care; whole blood; absogen pct; procalcitonin; semi quantitative

Journal Title: Journal of Clinical Laboratory Analysis
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.